Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-834P is a pseudogene annotated as derived from the human U6 small nuclear RNA family and is located at chromosome 12q13.12[2][4]. Pseudogenes like RNU6-834P are DNA sequences resembling functional genes but are generally non-coding and lack biological function, often resulting from duplication or retrotransposition events during genome evolution[5]. While functional U6 snRNA is a core component of the spliceosome responsible for the splicing of precursor mRNA in eukaryotic cells[1][3], RNU6-834P does not contribute to these activities. Its sequence tends to show substantial homology to authentic U6 RNA but harbors distinguishing features such as direct repeats and sequence truncations that render it non-functional[5]. There are no indications that RNU6-834P serves as a therapeutic target, a disease biomarker, or interacts with known drugs. If you seek information on the functional U6 snRNA itself, it plays a pivotal role in mRNA splicing as part of the spliceosome, not as a receptor, enzyme, or classic molecular target[1][3]. RNU6-834P is simply a genomic remnant documenting the evolutionary history of the U6 snRNA gene family.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 834, pseudogene (RNU6-834P).